Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.82 |
| ▸ | TYR | P14679 | 3/20 | 0.59 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.55 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516022 | 1.00 | PTPN1 (0.82) | PTPN1TYRPDCD1CD274HSP90AA1 | |
| SCHEMBL30523853 | 0.90 | PTPN1 (0.81) | PTPN1TYRHSP90AA1IDO1GABRA1 | |
| Licorisoflavan A SCHEMBL29907989 | 0.84 | PTPN1 (0.88) | PTPN1TYRPDCD1CD274HSP90AA1 | |
| SCHEMBL30288230 | 0.81 | PTPN1 (0.81) | PTPN1TYRHSP90AA1ACHEGABRA1 | |
| SCHEMBL5614193 | 0.80 | PTPN1 (1.00) | PTPN1TYRHSP90AA1ACHEGABRA1 | |
| SCHEMBL29375421 | 0.80 | PTPN1 (1.00) | PTPN1TYRHSP90AA1ACHEGABRA1 | |
| SCHEMBL571650 | 0.79 | HSP90AA1 (0.77) | PTPN1TYRHSP90AA1IDO1ACHE | |
| SCHEMBL30631321 | 0.78 | PTPN1 (0.81) | PTPN1TYRHSP90AA1ACHE | |
| Water SCHEMBL1999608 | 0.78 | HSP90AA1 (0.76) | PTPN1TYRHSP90AA1IDO1ACHE | |
| SCHEMBL26112000 | 0.78 | PTPN1 (0.81) | PTPN1TYRHSP90AA1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7888388-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-7888388-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-7524975-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7524975-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | PPARG, PPARA, PPARD | PTPN1 945/4885TYR 3814/4885PDCD1 2804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.